STRM vs. SST, ZENA, ZENV, LHSW, DUOT, ASST, LGCL, RMBL, ALAR, and ZSPC
Should you be buying Streamline Health Solutions stock or one of its competitors? The main competitors of Streamline Health Solutions include System1 (SST), ZenaTech (ZENA), Zenvia (ZENV), Lianhe Sowell International Group (LHSW), Duos Technologies Group (DUOT), Asset Entities (ASST), Lucas GC (LGCL), RumbleON (RMBL), Alarum Technologies (ALAR), and zSpace (ZSPC). These companies are all part of the "computer software" industry.
Streamline Health Solutions vs. Its Competitors
System1 (NYSE:SST) and Streamline Health Solutions (NASDAQ:STRM) are both small-cap computer software companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.
System1 has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, Streamline Health Solutions has a beta of 2.02, meaning that its share price is 102% more volatile than the S&P 500.
Streamline Health Solutions has lower revenue, but higher earnings than System1. Streamline Health Solutions is trading at a lower price-to-earnings ratio than System1, indicating that it is currently the more affordable of the two stocks.
In the previous week, Streamline Health Solutions had 1 more articles in the media than System1. MarketBeat recorded 2 mentions for Streamline Health Solutions and 1 mentions for System1. Streamline Health Solutions' average media sentiment score of 0.98 beat System1's score of 0.00 indicating that Streamline Health Solutions is being referred to more favorably in the news media.
System1 has a net margin of -23.99% compared to Streamline Health Solutions' net margin of -49.32%. Streamline Health Solutions' return on equity of -68.23% beat System1's return on equity.
87.5% of System1 shares are owned by institutional investors. Comparatively, 31.7% of Streamline Health Solutions shares are owned by institutional investors. 13.2% of System1 shares are owned by insiders. Comparatively, 30.6% of Streamline Health Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
System1 presently has a consensus target price of $50.00, indicating a potential upside of 731.95%. Given System1's higher probable upside, equities research analysts plainly believe System1 is more favorable than Streamline Health Solutions.
Summary
Streamline Health Solutions beats System1 on 10 of the 17 factors compared between the two stocks.
Get Streamline Health Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for STRM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding STRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Streamline Health Solutions Competitors List
Related Companies and Tools
This page (NASDAQ:STRM) was last updated on 7/3/2025 by MarketBeat.com Staff
